Veradigm | MDRX - Operating Expenses


Veradigm reported $126.92M in Operating Expenses for its fiscal quarter ending in September of 2022.





Operating Expenses Change Date
Alcidion AUD 22.7M 3.96M Jun/2025
Ambu A/S DKK 1.39B 75M Dec/2025
Amplifon EUR 539.04M 16.22M Sep/2025
Cardinal Health USD -2.88B 5M Dec/2025
Centene USD 50.96B 30.01B Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Cigna USD 41.71B 92.12M Dec/2025
Computer Programs Systems USD 87.92M 45.53M Sep/2023
Convatec Group USD 1B 518M Dec/2024
CVS Health USD 103.58B 3.66B Dec/2025
Diasorin EUR 224.05M 6.89M Sep/2025
Elevance Health USD 49.17B 5.21B Dec/2025
General Electric Aerospace USD 10.94B 7.87B Dec/2025
Gulf Medical Proj AED 182.97M 12.48M Dec/2025
Humana USD 33.32B 1.07B Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Maximus USD 1.72B 524.26M Dec/2025
McKesson USD 104.5B 2.85B Dec/2025
Med Life RON 747.87M 6.92M Sep/2025
Molina Healthcare USD 11.53B 191M Dec/2025
Omnicell USD 312.8M 13.16M Dec/2025
Oriola-kd EUR 456.7M 38.6M Sep/2025
Owens Minor USD -429.51M 1.05B Sep/2025
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Rede D'or Sao Luiz BRL 11.68B 21.3M Sep/2025
Siemens Healthineers EUR 4.73B 706M Dec/2025
Sonova Holding CHF 1.52B 59.9M Dec/2025
Supermax Corporation Bhd MYR 348.72M 89.13M Sep/2025
UnitedHealth USD 109.96B 1.11B Dec/2025
Veeva Systems USD 590.07M 19.69M Dec/2025
Veradigm USD 126.92M 29.33M Sep/2022
Xerox USD 365M 1.18B Sep/2025